This Dutch AI Startup Just Raised $2 Million to Transform Hearing Care

Jan de Vries · 2026-08-28

You know how sometimes a simple idea just clicks? That's what's happening in Maastricht, a city in the Netherlands. A startup called Clementine has just secured $2 million in Seed funding, and it's all about using artificial intelligence to tackle a problem affecting billions. Let's be honest, the hearing care industry has a massive disconnect. Clinics are busy, patients are hesitant, and meaningful conversations often get lost in the shuffle. That's the gap Clementine's founder, Vince van de Weijer, saw and decided to bridge with technology. ### The $2 Million Bet on AI The funding round was led by Healthy.Capital, an Amsterdam-based HealthTech investor. They've backed other promising names like Pharmi and OpenUp, so their vote of confidence here is significant. Douwe Jippes, managing partner at Healthy.Capital, put it perfectly: "Clementine combines deep domain expertise with a clear AI platform strategy that can scale globally. We believe this approach will fundamentally change how people with hearing disability engage with hearing healthcare." In other words, they're not just investing in software; they're investing in a new way for people to access care. ### Meet Matthew: The AI Agent Changing the Conversation So, what did they actually build? The core of their platform is an AI hearing care agent named Matthew. Think of Matthew as a compassionate, infinitely patient assistant who's available 24/7. - He answers questions without judgment and no waiting list. - He educates potential patients, helping them overcome both emotional and practical barriers. - He guides people toward the appropriate care, translating interest into actual clinic appointments. For clinics drowning in leads, this isn't just a nice-to-have. It eliminates administrative grunt work and directly turns inquiries into booked consultations. For patients, it means a streamlined, supportive first step. "Clinics don't need more leads; they need better conversations at the right moment," says CEO Vince van de Weijer. "Matthew ensures no patient inquiry goes unanswered." ### The Scale of the Problem and the Opportunity Let's talk numbers for a second, because they're staggering. Clementine points out that hearing loss affects roughly 1.5 billion people worldwide. Now get this: nearly 80% of those people never seek treatment. And for those who finally do? They typically wait over eight years before taking action. Eight years. That's a long time to struggle with something that profoundly impacts daily life. Clementine's approach is clever because it uses behavioral science alongside the AI. It creates a judgment-free, always-on entry point. People can start exploring their hearing care options privately, on their own terms, long before they're ready to walk into a physical clinic. They're meeting people where they are, emotionally and digitally. ### What's Next for Clementine? This Seed funding isn't happening in a vacuum. It comes right after the company expanded its reach through a partnership with Zoolstra, a marketing agency that works with hearing clinics across the United States and Canada. That's a clear signal of their transatlantic ambitions. The fresh capital has a clear mission: - Deepen the AI's capabilities (making Matthew even smarter and more helpful). - Expand partnerships beyond hearing clinics to include optical retailers and other healthcare organizations. It's about building an ecosystem, not just a tool. They're positioning themselves at the intersection of AI, healthcare, and human behavior—a space with incredible potential. For professionals watching the European startup scene, especially in HealthTech, Clementine is a case study worth watching. It shows how focused AI applications, built on deep industry insight, can attract serious investment and aim to solve a genuine, large-scale human problem. The journey from a Dutch city to potentially impacting global healthcare access is just beginning.